Retinal vessel oximetry in children with inherited retinal diseases

Background Alterations in retinal oxygen metabolism have already been confirmed in eldery subjects with retinitis pigmentosa (RP). Hovewer, whether this is a also a feature in children affected by RP has not been studied yet. The aim of our study was to compare retinal oxymetry (RO) parameters whith...

Full description

Saved in:
Bibliographic Details
Published inActa ophthalmologica (Oxford, England) Vol. 97; no. S263
Main Authors della Volpe Waizel, Maria, Scholl, Hendrik P.N., Valmaggia, Christophe, Todorova, Margarita G.
Format Journal Article
LanguageEnglish
Published Malden Wiley Subscription Services, Inc 01.12.2019
Subjects
Online AccessGet full text
ISSN1755-375X
1755-3768
DOI10.1111/j.1755-3768.2019.5221

Cover

Abstract Background Alterations in retinal oxygen metabolism have already been confirmed in eldery subjects with retinitis pigmentosa (RP). Hovewer, whether this is a also a feature in children affected by RP has not been studied yet. The aim of our study was to compare retinal oxymetry (RO) parameters whithin children with inherited retinal diseases (IRDs), as well as agains those of carriers and healthy controls. Methods A total of 68 children (136 eyes) of were examined: 16 with IRDs (32 eyes) were compared to those of 11 IRD carriers (22 eyes) and of 41 healthy children (82 eyes). RO was performed with the oxygen saturation tool of the Retinal Vessel Analyser (RVA; IMEDOS, Germany). The mean oxygen saturations, within 1.0–1.5 optic disc diameters from the disc margin, in the retinal arterioles (A‐SO2;%) and venules (V‐SO2;%) were estimated and their difference (A‐V SO2;%), was calculated. The corresponding arterioles (D‐A;μm) and venules (D‐V;μm) were evaluated, as well. For statistical evaluation ANOVA‐based linear mixed‐effects models were calculated with SPSS®. Results The V‐SO2 showed a statistically significant increase in RP eyes (67.00 ± 7.48%) when compared to healthy controls (59.07 ± 11.98%, p=0.03), but also to children with other IRDs and to carriers (p ≤ 0.03). The A‐V SO2 showed a statistically significant decrease in RP eyes (32.62 ± 4.03%), when compared to eyes suffering from macular dystrophies (MD, 44.35 ± 10.55%, p = 0.05) or cone‐rod‐dystrophies (CRD, 43.29 ± 10.55, p = 0.03). The D‐V, even if not reaching statistically significant level, showed a trend for RP to be slightly attenuated (102.31 ± 8.20 μm) when compared to controls (108.76 ± 20.87 μm; p = 0.07). Conclusion These data indicate that children suffering RP show early metabolic alterations. With aging and progression of RP the sign of vascular attenuation seems to be a secondary effect of neurovascular remodeling. Here, RO seems to be a useful screening tool for metabolic dysfunction within a family affected from RP.
AbstractList Background Alterations in retinal oxygen metabolism have already been confirmed in eldery subjects with retinitis pigmentosa (RP). Hovewer, whether this is a also a feature in children affected by RP has not been studied yet. The aim of our study was to compare retinal oxymetry (RO) parameters whithin children with inherited retinal diseases (IRDs), as well as agains those of carriers and healthy controls. Methods A total of 68 children (136 eyes) of were examined: 16 with IRDs (32 eyes) were compared to those of 11 IRD carriers (22 eyes) and of 41 healthy children (82 eyes). RO was performed with the oxygen saturation tool of the Retinal Vessel Analyser (RVA; IMEDOS, Germany). The mean oxygen saturations, within 1.0–1.5 optic disc diameters from the disc margin, in the retinal arterioles (A‐SO2;%) and venules (V‐SO2;%) were estimated and their difference (A‐V SO2;%), was calculated. The corresponding arterioles (D‐A;μm) and venules (D‐V;μm) were evaluated, as well. For statistical evaluation ANOVA‐based linear mixed‐effects models were calculated with SPSS®. Results The V‐SO2 showed a statistically significant increase in RP eyes (67.00 ± 7.48%) when compared to healthy controls (59.07 ± 11.98%, p=0.03), but also to children with other IRDs and to carriers (p ≤ 0.03). The A‐V SO2 showed a statistically significant decrease in RP eyes (32.62 ± 4.03%), when compared to eyes suffering from macular dystrophies (MD, 44.35 ± 10.55%, p = 0.05) or cone‐rod‐dystrophies (CRD, 43.29 ± 10.55, p = 0.03). The D‐V, even if not reaching statistically significant level, showed a trend for RP to be slightly attenuated (102.31 ± 8.20 μm) when compared to controls (108.76 ± 20.87 μm; p = 0.07). Conclusion These data indicate that children suffering RP show early metabolic alterations. With aging and progression of RP the sign of vascular attenuation seems to be a secondary effect of neurovascular remodeling. Here, RO seems to be a useful screening tool for metabolic dysfunction within a family affected from RP.
BackgroundAlterations in retinal oxygen metabolism have already been confirmed in eldery subjects with retinitis pigmentosa (RP). Hovewer, whether this is a also a feature in children affected by RP has not been studied yet. The aim of our study was to compare retinal oxymetry (RO) parameters whithin children with inherited retinal diseases (IRDs), as well as agains those of carriers and healthy controls.MethodsA total of 68 children (136 eyes) of were examined: 16 with IRDs (32 eyes) were compared to those of 11 IRD carriers (22 eyes) and of 41 healthy children (82 eyes). RO was performed with the oxygen saturation tool of the Retinal Vessel Analyser (RVA; IMEDOS, Germany). The mean oxygen saturations, within 1.0–1.5 optic disc diameters from the disc margin, in the retinal arterioles (A‐SO2;%) and venules (V‐SO2;%) were estimated and their difference (A‐V SO2;%), was calculated. The corresponding arterioles (D‐A;μm) and venules (D‐V;μm) were evaluated, as well. For statistical evaluation ANOVA‐based linear mixed‐effects models were calculated with SPSS®.ResultsThe V‐SO2 showed a statistically significant increase in RP eyes (67.00 ± 7.48%) when compared to healthy controls (59.07 ± 11.98%, p=0.03), but also to children with other IRDs and to carriers (p ≤ 0.03). The A‐V SO2 showed a statistically significant decrease in RP eyes (32.62 ± 4.03%), when compared to eyes suffering from macular dystrophies (MD, 44.35 ± 10.55%, p = 0.05) or cone‐rod‐dystrophies (CRD, 43.29 ± 10.55, p = 0.03). The D‐V, even if not reaching statistically significant level, showed a trend for RP to be slightly attenuated (102.31 ± 8.20 μm) when compared to controls (108.76 ± 20.87 μm; p = 0.07).ConclusionThese data indicate that children suffering RP show early metabolic alterations. With aging and progression of RP the sign of vascular attenuation seems to be a secondary effect of neurovascular remodeling. Here, RO seems to be a useful screening tool for metabolic dysfunction within a family affected from RP.
Abstract only
Author della Volpe Waizel, Maria
Todorova, Margarita G.
Valmaggia, Christophe
Scholl, Hendrik P.N.
Author_xml – sequence: 1
  givenname: Maria
  surname: della Volpe Waizel
  fullname: della Volpe Waizel, Maria
  organization: University of Basel
– sequence: 2
  givenname: Hendrik P.N.
  surname: Scholl
  fullname: Scholl, Hendrik P.N.
  organization: IOB – Institute of Molecular and Clinical Ophthalmology Basel
– sequence: 3
  givenname: Christophe
  surname: Valmaggia
  fullname: Valmaggia, Christophe
  organization: Cantonal Hospital St. Gallen
– sequence: 4
  givenname: Margarita G.
  surname: Todorova
  fullname: Todorova, Margarita G.
  organization: Cantonal Hospital St. Gallen
BookMark eNqNkN1LwzAQwINMcJv-CULB59Z8NE3i2xg6hcHAD_AttM2FpXTtTDrn_ntbN_bsvdxxd7_j-E3QqGkbQOiW4IT0cV8lRHAeM5HJhGKiEk4puUDjc3d0rvnnFZqEUGGckSxLx2j-Cp1r8jr6hhCgjtoft4HOHyLXROXa1cZDE-1dt-4ba_CuAxP5E2JcgDxAuEaXNq8D3JzyFH08Pb7Pn-PlavEyny3jklBOYioVCMkyRkiJpaIFsUJQYQgvCwmG5iaVacGtLVShqJKKW2ks5aWkYDCVbIrujne3vv3aQeh01e58_0nQlPVzwUTK-i1-3Cp9G4IHq7febXJ_0ATrwZeu9GBDD2b04EsPvnru4cjtXQ2H_0F6tnr7g38BlnNwnw
ContentType Journal Article
Copyright 2019 The Authors Acta Ophthalmologica © 2019 Acta Ophthalmologica Scandinavica Foundation
Copyright © 2019 Acta Ophthalmologica Scandinavica Foundation
Copyright_xml – notice: 2019 The Authors Acta Ophthalmologica © 2019 Acta Ophthalmologica Scandinavica Foundation
– notice: Copyright © 2019 Acta Ophthalmologica Scandinavica Foundation
DBID AAYXX
CITATION
7TK
DOI 10.1111/j.1755-3768.2019.5221
DatabaseName CrossRef
Neurosciences Abstracts
DatabaseTitle CrossRef
Neurosciences Abstracts
DatabaseTitleList
Neurosciences Abstracts
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1755-3768
EndPage n/a
ExternalDocumentID 10_1111_j_1755_3768_2019_5221
AOS5221
Genre abstract
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
1OC
23M
24P
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACUHS
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
GODZA
H.X
HF~
HGLYW
HZI
HZ~
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2W
P2X
P2Z
P4B
P4D
P6G
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
1OB
7TK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c1251-289e7836311c0892b1f7727d15cb8ed2ad484b5ffb9b929895f8df25c82ed0283
IEDL.DBID DR2
ISSN 1755-375X
IngestDate Wed Aug 13 03:11:14 EDT 2025
Tue Jul 01 01:55:24 EDT 2025
Wed Jan 22 16:37:44 EST 2025
IsPeerReviewed true
IsScholarly true
Issue S263
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1251-289e7836311c0892b1f7727d15cb8ed2ad484b5ffb9b929895f8df25c82ed0283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
PQID 2328373743
PQPubID 1036384
PageCount 1
ParticipantIDs proquest_journals_2328373743
crossref_primary_10_1111_j_1755_3768_2019_5221
wiley_primary_10_1111_j_1755_3768_2019_5221_AOS5221
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2019
2019-12-00
20191201
PublicationDateYYYYMMDD 2019-12-01
PublicationDate_xml – month: 12
  year: 2019
  text: December 2019
PublicationDecade 2010
PublicationPlace Malden
PublicationPlace_xml – name: Malden
PublicationTitle Acta ophthalmologica (Oxford, England)
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
SSID ssj0061664
Score 2.241771
Snippet Background Alterations in retinal oxygen metabolism have already been confirmed in eldery subjects with retinitis pigmentosa (RP). Hovewer, whether this is a...
Abstract only
BackgroundAlterations in retinal oxygen metabolism have already been confirmed in eldery subjects with retinitis pigmentosa (RP). Hovewer, whether this is a...
SourceID proquest
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
SubjectTerms Aging
Arterioles
Children
Eye
Metabolism
Oxygen
Retina
Retinitis
Retinitis pigmentosa
Statistical analysis
Title Retinal vessel oximetry in children with inherited retinal diseases
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1755-3768.2019.5221
https://www.proquest.com/docview/2328373743
Volume 97
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS8MwFA5jB_Hib3E6Rw9eW5amaZvjmM6pqDAd7FaaNsGhdrJ1ov71vtemc9OLiKdCaUL7-l7yveR9Xwg54Uq7UjNhy4Rz20upa8cw7NkSTyuUScpYUe1-feP3h97liI9q5LziwpT6EIsFN4yMYrzGAI_lbDXIA-geAqSo0BIOIAlMgyjzUUP_dLCQkfKpX8hImef5yDB5qoqeH72szlFfwHMZvhbzT2-TPFRvXpadPDrzXDrJxzdRx3_4tC2yYTCq1SmdapvUVLZD1q7NLvwu6Q6QJw1PvKLw-JM1eRs_q3z6bo0zqyKHW7jACzeQXgig1pqaJmZDaLZHhr2z-27fNocx2AliIBsSM4WMD0Zp0g6FK6kGYB6klCcyVKkbp17oSa61FFKgrDvXYapdnoSuShHE7JN6NsnUAbHiUHgp0zSgsfQCoUXY1uAfVMN4wL2YNohTmT96KTU3oqVcBUwToWkiNE2EpmmQZvWTIhOCswigIiTfDBBSg7DC2r_rLOrc3uH18E-tjsi6C1lhyVZskno-natjgC25bIFPXly1Cs_8BEc63lY
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8NAEB5KBfXiW6xWzcFrQjfJNsmxFEvUtkJtobclm2ShqKm0qai_3pk8aqsXEU-BJLNkJzuz3-zOfAtwxWNlSmV5ugw51-2ImXqAbk-XdFqhDCPLyrLde_2mP7Jvx3xcAb-shcn5IZYLbmQZmb8mA6cF6XUrd7B9tJAsRcszEEpgHLSR7dURPBosiaSarJkRSRUCfFzU8pQ5PT-aWZ-lvqDnKoDNZqDOLkzKb88TTx6NRSqN8OMbreN_dG4PdgqYqrXycbUPlTg5gM1esRF_CO0BlUrjG6_EPf6kTd8mz3E6e9cmiVbWh2u0xos3qMIQca02K0SKPaH5EYw618O2rxfnMeghwSAdY7OYij4sxsKG65mSKcTmTsR4KN04MoPIdm3JlZKe9IjZnSs3UiYPXTOOCMccQzWZJvEJaIHr2ZGlmMMCaTue8tyGwiHCFLoEbgesBkapf_GS026IlXAFVSNINYJUI0g1NaiXf0kUVjgXiBYx_rYQJNXAytT9u8ZE6_6Brqd_krqELX_Y64ruTf_uDLbpeZ7_UodqOlvE54hiUnmRDdBPFsLhdw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retinal+vessel+oximetry+in+children+with+inherited+retinal+diseases&rft.jtitle=Acta+ophthalmologica+%28Oxford%2C+England%29&rft.au=della+Volpe+Waizel%2C+Maria&rft.au=Scholl%2C+Hendrik+P.N.&rft.au=Valmaggia%2C+Christophe&rft.au=Todorova%2C+Margarita+G.&rft.date=2019-12-01&rft.issn=1755-375X&rft.eissn=1755-3768&rft.volume=97&rft.issue=S263&rft_id=info:doi/10.1111%2Fj.1755-3768.2019.5221&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1755_3768_2019_5221
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-375X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-375X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-375X&client=summon